Adu Subramanian
MD Student, Investor, Builder writing adus.substack.com. Website www.subradata.com,
Still on Twitter @plainyogurt21
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@rubensebas.bsky.social
Biotech VC investor | Board member | Talking about science, therapeutics, drug development, startups and pharma | PhD @crg.eu https://www.linkedin.com/in/rubensebastianperez/
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@ashwinvarma97.bsky.social
Currently: MD Student @UTHealthSA. Former: Associate @BCG, Clinical Trials @MDAndersonNews, External R&D @Celgene, Summer Associate, @Lux_Capital. Views my own.
@biopharmcatalyst.bsky.social
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks https://www.biopharmcatalyst.com/
@maxx.living.tech
Founder of Solt DB (@living.tech) Solt DB is a biotech equities research firm and public benefit company. We help investors understand science, and scientists understand the business of biotech. https://www.living.tech/
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@emollick.bsky.social
Professor at Wharton, studying AI and its implications for education, entrepreneurship, and work. Author of Co-Intelligence. Book: https://a.co/d/bC2kSj1 Substack: https://www.oneusefulthing.org/ Web: https://mgmt.wharton.upenn.edu/profile/emollick
@natolambert.bsky.social
A LLN - large language Nathan - (RL, RLHF, society, robotics), athlete, yogi, chef Writes http://interconnects.ai At Ai2 via HuggingFace, Berkeley, and normal places
@mppai.bsky.social
Biotech investor relations. Voracious reader, eater & wine drinker. Personal account; posts & opinions are my own. she/her
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@adrianh.bsky.social
Je ne te parle pas, je chante pour moi-même, je chante pour moi-même! Et je pense! il n'est pas défendu de penser! I don’t like bullies. computational biology, biotech, machine learning, short-selling www.logphase.com
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@supersciencegrl.co.uk
Digital chemist & chemistry automation nerd | Lives in a historical canalside cottage | "Aggressively sciency" | Views are mine | She/they. Macclesfield, UK
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@laurahowes.bsky.social
Editor (she/her) @cenmag.bsky.social into biomolecules, drug discovery, and biotech. Also beer, skiing, and the joys of being an immigrant in Germany. All views expressed here are absolutely mine, especially when they're right. DM for Signal.
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@crick.ac.uk
We're the Crick, a biomedical research lab in London working to figure out how life works. Home to more than 2,000 scientists and a free public exhibition space. https://www.crick.ac.uk/
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@ricklivesey.bsky.social
Cellular and molecular neuroscience, neurodegeneration & drug discovery. Founder and CEO of Talisman Therapeutics & Gen2 Neuroscience, honorary prof at UCL. Cambridge UK.
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@shafferbiotech.bsky.social
Biotech entrepreneur and consultant. Biochem PhD. Opinions strictly my own.
@rowanbio.bsky.social
Founder & CBIO @precisionlife.bsky.social, NED @dhcwales.bsky.social & STFC Innovations Limited. Former Juror for Cartier Women's Initiative. Interests #bio #diversity #ai #techbio #climate #precisionmedicine #digitalhealth personal account
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & functional longevity. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@robertcoffin.bsky.social
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
@ntilmans.bsky.social
Founder/CEO Anagenex working at edge of biochemistry+tech. Waffle enthusiast.
@robwinder.bsky.social
Life science and healthcare business communicator Early talent recruitment coordinator for strategic communications at FTI Consulting in London. The views expressed are my own, and should not be considered to be the views of my employer.
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@dempsey.bsky.social
@bobjherman.bsky.social
Health care business reporter for @statnews.com and its Health Care Inc. newsletter. Contact: bob.herman@statnews.com or bobjherman.09 on Signal. Sign up: https://www.statnews.com/signup/health-care-inc/